期刊文献+

晚期大肠癌维持性治疗的研究现状及展望 被引量:2

Current status and future about maintenance treatment of advanced colorectal cancer
原文传递
导出
摘要 通过PubMed、CNKI等数据库检索有关晚期大肠癌维持治疗的相关原始文献,整理并分析了晚期大肠癌在维持治疗方面的研究理论和进展,评价了维持治疗的临床疗效,重点观察患者的无瘤生存期和生活质量。结果显示晚期大肠癌患者经过维持治疗可提高患者的无瘤生存期,维持治疗的毒副反应尚可耐受。晚期大肠癌的维持治疗有较好的临床疗效,值得进一步研究探讨。 Through PubMed, CNKI and other databases to retrieve original documents about the maintenance treatment of advanced colorectal cancer, collect and analyzed research theory and progress in the maintenance treatment of advanced colorectal cancer. The clinical efficacy of maintenance therapy are evaluated and the patient's disease-free survival and quality of life are observed. The Result shows that the maintenance treatment can improve disease-free survival of advanced colorectal cancer patients, and the toxicity of maintenance treatment can still be tolerated. So the maintenance treatment of advanced colorectal cancer has better clinical efficacy, it is worth to study in the future.
出处 《肿瘤研究与临床》 CAS 2011年第8期567-569,共3页 Cancer Research and Clinic
基金 北京中医科技资助项目(JJ-2010-04)
关键词 肠肿瘤 抗肿瘤联合化疗方案 中草药 研究 Intestinal ueoplasms Antineoplastie combined chemotherapy protocols Drugs, chinese herbal Research
  • 相关文献

参考文献13

  • 1Ries LAG,Melbert D,Krapcho M,et al.SEER Cancer Statistics Review,1975-2004.Bethesda,MD:National Cancer Institute,Available at http://seer.cancer.gov/csr/1975_2004/.accessed November 15,2007.
  • 2白维君,张霞,王大中.进展期非小细胞肺癌维持治疗进展[J].医学与哲学(B),2009,30(6):17-19. 被引量:7
  • 3Goldie JH,Coldman AJ,Gudauskas GA.Rationale for the use of alternating non-cross-resistant chemotherapy.Cancer Treat Rep,1982,66:439-449.
  • 4Petrioli R,Paolelli L,Marsili S,et al.FOLFOX-4 Stop and Go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer.Oncology,2006,70:345-350.
  • 5Sun JF,Wu RR,Norris C,et al.Safety of chronic low dose capecitabine as maintenance therapy in gastrointestinal cancers.Gastrointestinal Cancer Res,2009,3:134-140.
  • 6Li YH,Luo HY,Wang FH,et al.Phase Ⅱ study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.J Cancer Res Clin Oncol,2010,136:503-510.
  • 7Chibaudel B,Maindrault-Goebel F,Lledo G,et al.Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.J Clin Oncol,2009,27:5727-5733.
  • 8Ardavanis A,Kountourakis P,Mantzaris I,et al.Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer:a well-tolerated,active and convenient regimen.Anticancer Research,2008,28:3087-3092.
  • 9Assessment Report For Erbitux,No.EMEA/H/C000558/11/0020,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment _Report_-_Variation/human/000558/WC500029117.pdf.
  • 10赵文硕,张青,于洁,王笑民.加味升血汤配合化疗治疗中晚期大肠癌的临床研究[J].国际中医中药杂志,2006,28(5):306-308. 被引量:17

二级参考文献31

共引文献53

同被引文献5

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部